2% Lidocaine HCl topical solution for Postoperative Nausea and Vomiting

"A 2% Lidocaine HCl topical solution can be applied to treat a range of conditions, such as raised intra ocular pressure (iop), nasal discomfort, and the over-production of dangerous substances in the kidneys."

"Unfortunately, recruitment for this trial has closed as of April 6th 2022. However, if you are looking to join a medical study there are still 115 trials actively searching for participants with postoperative nausea and 211 studies recruiting patients who need 2% Lidocaine HCl topical solution."

"Presently, 211 clinical trials are being conducted pertaining to the efficacy of 2% Lidocaine HCl topical solution. Out of these active studies, 53 have reached Phase 3 testing. The preponderance of research for this treatment is centered in Duarte, California; however there are 1,461 different sites running experiments across the globe."

"At this moment, clinicaltrials.gov does not list the trial as actively recruiting participants. This experiment was initially posted in October 2022 and revised last April yet is currently dormant; however, there are 326 other research trials searching for volunteers at present."

"There is ample evidence for the safety of 2% Lidocaine HCl topical solution, thus receiving a score of 3 on our evaluation scale. This compound has been approved by the FDA and is currently in Phase 4 trials."